KB 2611

Drug Profile

KB 2611

Alternative Names: KB 002611

Latest Information Update: 21 Dec 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Karo Bio
  • Class Skin disorder therapies
  • Mechanism of Action Thyroid hormone receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Skin disorders

Most Recent Events

  • 06 May 2002 Data from a media release have been added to the Skin Disorders therapeutic trials section
  • 15 Oct 2001 KB 2611 is available for licensing (http://www.karobio.se/)
  • 15 Oct 2001 Phase-II clinical trials for Skin disorders in Sweden (Topical)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top